EmailThe healthcare sector +0.9% is trading higher today slightly outperforming the S&P 500 +0.6%.
News: DVAX (+23.4%) announces FDA agrees with Dynavax on consistency of HEPLISAV lots, MBLX (+15.2%) and CJ CheilJedang announce joint development agreement for commercialization of renewable C4 chemicals; financial terms not disclosed, LXRX +7.7% IBS drug candidate, LX1033, successfully completes Phase 1 clinical trial, BSX +9.2% announces $1 billion share repurchase program, ECYT +7.1% increases size of offering and prices 5,809,931 shares of its common stock at $12.26 per share, MRGE +5.1% reports St. Mary's Regional Medical Center selects MRGE for Cardiology Image and Information System, IRWD +1.4% and Depomed (DEPO) announce collaboration, research and license agreement, CCM +2.0% declared special dividend of $0.06/share, PACB +1.6% DNA sequencing technology yields new insights into virulence and evolution of German E. coli Pathogen, AMLN +1.3%, LLY +1.2%, and ALKS +1.5% reply to FDA in regard to BYDUREON, BPAX -4% prices public offering of common stock at $3.00/share; proceeds expected to be ~ $45 million, VAR -5.1% awarded major contract to supply advanced radiotherapy equipment to Scotland's cancer centers, and PSID -10.5% announced that it has entered agreements with Ironridge Global Technology, under which Ironridge to purchase common and preferred stock totaling up to $13.8 million.
Broker Research: VAR -5.1% downgraded at Baird, HLS +7.1% upgraded at JMP Securities, EM -5.3% downgraded at William Blair, NPSP +2.1% resumed with a Buy at Brean Murray, OSUR +7.2% initiated with a Buy at Madison Williams, REGN +6.3% upgraded at RBC Capital, MBLX +15.2% upgraded at Feltl, IMUC -4% initiated with a Buy at Summer Street
Rumors: SPPI +3.4% following a story that Teva (TEVA) could be interested in the co.
